top of page

Members

Finding Inspiration in Every Turn

Please meet some excellent researchers who are passionate

about their research and work!

Lab 2025_edited_edited.jpg

Team

Dedication. Expertise. Passion.

bafkreieieexu6c6rkdfk52lvkataw5ny4mda5b5

Principal Investigator 

Dr. Nimrat Chatterjee

I love thinking about the why and how of mutation formation in cells. In addition to my passion for scientific research, I love mentoring, writing, and teaching. Outside of Science, I am a marathon runner and love action movies, knitting, rock climbing, and gardening!


nimrat.chatterjee@med.uvm.edu
nimratchatterjee@gmail.com
  • Facebook
  • Twitter
  • LinkedIn
lab pic.jpg

Graduate student

Sombodhi Bhattacharya

I am a first-year graduate student in the CMB program, with a keen interest in unraveling the mechanisms of Rev1-dependent DNA damage response and its potential role in therapeutic resistance to cancer, including chemoresistance and radio resistance. Outside the lab, I enjoy playing the piano, producing music and background scores for short films, and exploring the beauty of our planet. I am excited for the journey ahead in the Chatterjee lab and look forward to my research years.

image.png

Undergraduate student

Maddie Guyette

I just started in the Chatterjee lab this fall and am currently learning more about the REV1 pathway, scientific techniques, and the projects being researched. Outside of the lab, I enjoy hiking, hockey, pickleball, and art! 

Headshot.JPG

Undergraduate student

Naveen Kothandraman

I am pursuing a B.S. in Microbiology & Molecular Genetics. I am interested in studying how REV1 regulates switches in cell death pathway choice, specifically autophagy and senescence. In my free time, I enjoy playing tennis, singing, and watching sports!

Cancer genetics_edited.jpg

Undergraduate student

Quinn

text

IMG_0644_edited_edited.jpg

Undergraduate student

Katie Boyle

text

IMG_0644_edited.jpg

Undergraduate student

Katie Fonden

Colin investigates cytotoxicity and metabolic impact of the use of novel translesion synthesis inhibitors for cancer treatment. 

bottom of page